medigraphic.com

2020, Number 2

<< Back Next >>

Cuba y Salud 2020; 15 (2)

Pigmentary incontinence in pregnant women with normal alenewborn

Santoyo RFA, Rondon GR, Hernández HZ, Sabiñon DO

Language: Spanish
References: 18
Page: 60-64
PDF size: 644.76 Kb.


ABSTRACT

Incontinentia pigmenti, also known as Bloch-Sulzberger syndrome, is an X-linked dominant neurocutaneous syndrome, which variably affects the tissues derived from the neuroectoderm and mesoderm including the skin, hair, nails, eyes, central nervous system and teeth. The typical skin symptoms of this condition consist of four stages: vesicular, verrucous, hyperpigmented and atrophic. This paper report one case of adult patient in the Manuel Fajardo’s clinic, who had clear skin manifestations of the disease and so far no extracutaneous manifestations. This publication is important considering the rarity of this condition, the unusual fact of male fetus survival after the 20th week, the importance of knowing the diagnosis in pregnant women for a suita ble tracing of his gravidity; and because we didn´t find any study in women with this condition.


REFERENCES

  1. García Y, Castillo G. Incontinencia pigmenti en un recién nacido. Presentación de un caso. Medisur [Internet]. 2015 [citado 30 abril 2020]; 13 (4): 555-559. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2015000400013&lng=es

  2. Morelli J. Lesiones hiperpigmentadas. En: Behrman R, Kliegman R, Jenson H. Nelson Tratado de Pediatría. 18 ed. Barcelona: Elsevier, 2006: 2681-2.

  3. Matelzonas T, Ruvertoni M, Reyno S, Pinchak MC. Incontinentia pigmenti. Presentación neonatal: A propósito de un caso clínico. Arch. Pediatr. Urug. [Internet]. 2010 [citado 30 abril 2019]; 81(1): 23-29. Disponible en: http://www.scielo.edu.uy/scielo. php?script=sci_arttext&pid=S1688-12492010000100004&lng=es

  4. Lapeere H, Boone B, De Schepper S, Verhaeghe E, Ongenae K, Van Gell N, et al. Hipomelanosis e hipermelanosis. En: Wolff K, Goldsmith L, Katz S, et al. Fitzpatrick dermatología en medicina General. 7 ed. Buenos Aires: Panamericana, 2015

  5. Poziomczyk CS, Recuero JK, Bringhenti L, et al. Incontinentia pigmenti. An Bras Dermatol [Internet]. 2014 (citado 30 abril 2019); 89(1): 26-36. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962014000100026&lng=en

  6. Swamy DKN, Arunagirinathan A, Krishnakumar R y Sangili S. Incontinentia pigmenti: a rare genodermatosis in a male child, J Clin Diag Res [Internet]. 2015 (citado 30 abril 2019); 9(2): SD06-SD8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4378780/

  7. Kenwrick S, Woffendin H, Jakins T, Shuttleworth SG, Mayer E, Greenhalgh L, et al. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet [Internet]. 2001 (citado 30 abril 2019); 69 (6): 1210-1217. Disponible en: https://www.sciencedirect.com/science/article/pii/S0002929707612506

  8. Hull S, Arno G, Thomson P et al. Somatic mosaicism of a novel IKBKG mutation in a male patient with incontinentia pigmenti, Am J Med Genet [Internet]. 2015 (citado 25 abril 2019); 167(7): 1601-1604. Disponible en: https://onlinelibrary.wiley.com/doi/ full/10.1002/ajmg.a.37004

  9. Marques GF, Tonello CS, Sousa JMP. Incontinentia pigmenti or Bloch-Sulzberger syndrome: a rare x-linked genodermatosis, An Bras Dermatol [Internet]. 2014 (citado 25 abril 2019); 89(3): 486-489. Disponible en: http://www.scielo.br/scielo.php?script=sci_ arttext&pid=S0365-05962014000300486&lng=en

  10. Rosenthal AC, Fölster-Holst R. Incontinentia pigmenti, Der Hautarzt 2016, 4 pp.

  11. Ehrenreich M, Tarlow MM, Godlewska-Janusz E, Schwartz RA. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder. CUTIS-NEW YORK [Internet]. 2007; 79 (5): 355-362. Disponible en: https://mdedge-files-live.s3.us-east-2.amazonaws. com/files/s3fs-public/Document/September-2017/079050355.pdf

  12. Dupati A, Egbers RG, Helfrich YR. A case of incontinentia pigmenti reactivation after 12-month immunizations. JAAD Case Reports [Internet]. 2015 (citado 23 abril 2019); 1(6): 351-352. Disponible en: https://www.jaadcasereports.org/article/S2352- 5126(15)00138-1/fulltext

  13. Pacheco TR, Levy M, Collyer JC, de Parra NP, Parra CA, Garay M, et al. Incontinentia pigmenti in male patients. J Am Acad Dermatol [Internet]. 2016 (citado 25 abril 2019); 55 (2): 251-255. Disponible en: https://www.sciencedirect.com/science/article/ abs/pii/S0190962205047195

  14. Chan YC, Happle R, Giam YC. Whorled scarring alopecia: A rare phenomenon in incontinentia pigmenti?. J Am Acad Dermatol [Internet]. 2003 (citado 23 abril 2019); 49: 929-931. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/ S0190962203004742

  15. Donnai D. Incontinentia pigmenti (Chapter 130). En: Irvine AD, Hoeger PH, Yan AC. (eds.). Harper’s Textbook of Pediatric Dermatology. 3rd ed. Wiley- Blackwell; 2014. p. 1725-31.

  16. Kaya TI, Tursen U y Ikizoglu G. Therapeutic use of topical corticosteroids in the vesiculobullous lesions of incontinentia pigmenti, Clin Exp Dermatol 2016; 34(8): e611-3.

  17. Kataguiri P, Martins FCR, Yamada V, Salomão G, Ribeiro R, Rehder JRCL. Manifestações clínicas e desafios diagnósticos na Síndrome de incontinentia pigmenti. Rev Bras Oftalmol [Internet]. 2015 (citado 23 abril 2019); 69 (6): 395-399. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802010000600009&lng=en

  18. Buinauskienë J, Buinauskaitë E, Valiukevicienë S. Incontinentia pigmenti in neonates. Medicina (Kaunas). 2005; 41 (6): 496-9.




2020     |     www.medigraphic.com